After-hours movers: Zscaler falls following results, Carlyle gains on S&P MidCap 400 nod
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
UBS downgrades ChargePoint (CHPT) to Neutral as topline trajectory becomes less certain
November 28, 2023 8:36 AM ESTUBS has downgraded ChargePoint Holdings (NYSE: CHPT) to a Neutral rating (From Buy)and cut the 12-month price target on the stock to $2.25 (From $9.00) as the companys topline trajectory has become less clear.
CHPT maintains its position as the primary shareholder in the U.S. for Level 2 (L2) charging ports. With a market share increase this year, the company now holds 44% of the... More
Confluent, Inc. (CFLT) an 'attractive revenue story' - Bernstein
November 28, 2023 8:01 AM ESTConfluent, Inc. (NASDAQ: CFLT) was initiated with an Outperform rating and $34 per share price target by Bernstein analyst Peter Weed in a note Tuesday.
Weed told investors in a note that CFLT is an "attractive revenue story" with tailwinds from cloud adoption, with a... More
Zscaler (ZS) PT Raised to $200 at BMO Capital
November 28, 2023 6:25 AM ESTBMO Capital analyst Keith Bachman raised the price target on Zscaler (NASDAQ: ZS) to $200.00 (from $195.00) while maintaining an Outperform rating.
The analyst commented, "ZS reported a reasonable quarter across the board, though ~4pts of billings growth upside was perhaps less than investors... More
